197 related articles for article (PubMed ID: 37550123)
1. Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.
Toth GG; Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Choi JW; Caputo R; Troquay R; Diderholm E; Singh S; Brar SS; Loussararian A; Chetcuti S; Tulli M; Stone GW; Lung TH; Mylotte D
Cardiovasc Revasc Med; 2024 Jan; 58():60-67. PubMed ID: 37550123
[TBL] [Abstract][Full Text] [Related]
2. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
Kandzari DE; Kirtane AJ; Mehran R; Price MJ; Simon DI; Latib A; Kedhi E; Abizaid A; Worthley SG; Zaman A; Hudec M; Stoler R; Choi JW; Kanitkar M; Conradie A; Tam CF; Walton A; Gruberg L; Ando K; Lee LC; Lung TH; Windecker S; Stone GW
Catheter Cardiovasc Interv; 2022 Feb; 99(3):583-592. PubMed ID: 34478233
[TBL] [Abstract][Full Text] [Related]
4. One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Choi JW; Caputo R; Kanitkar M; McLaurin B; Potluri S; Smith T; Spriggs D; Tolleson T; Nazif T; Parke M; Lee LC; Lung TH; Stone GW;
Circ Cardiovasc Interv; 2020 Nov; 13(11):e009565. PubMed ID: 33167705
[TBL] [Abstract][Full Text] [Related]
5. Design and Rationale of the BIOFLOW-DAPT Trial: a Prospective, Randomized, Multicenter Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination with 1-Month Dual Antiplatelet Therapy.
Landi A; Wlodarczak A; Tölg R; Kelbæk H; Legutko J; Galli S; Godin M; Toth GG; Lhermusier T; Honton B; Dietrich PL; Stammen F; Ferdinande B; Silvain J; Capodanno D; Cayla G; Valgimigli M;
J Cardiovasc Transl Res; 2023 Oct; 16(5):1135-1143. PubMed ID: 37264295
[TBL] [Abstract][Full Text] [Related]
6. Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.
Windecker S; Latib A; Kedhi E; Kirtane AJ; Kandzari DE; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Hudec M; Poliacikova P; Kahar Bin Abdul Ghapar A; Selvaraj K; Petrov I; Mylotte D; Pinar E; Moreno R; Fabbiocchi F; Pasupati S; Kim HS; Aminian A; Tie C; Wlodarczak A; Hur SH; Marx SO; Ali ZA; Parke M; Lung TH; Stone GW;
JACC Cardiovasc Interv; 2022 Jun; 15(11):1153-1163. PubMed ID: 35680195
[TBL] [Abstract][Full Text] [Related]
7. A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.
Tarantini G; Fovino LN; Varbella F; Trabattoni D; Caramanno G; Trani C; De Cesare N; Esposito G; Montorfano M; Musto C; Picchi A; Sheiban I; Gasparetto V; Ribichini FL; Cardaioli F; Saccà S; Cerrato E; Napodano M; Martinato M; Azzolina D; Andò G; Mugnolo A; Caruso M; Rossini R; Passamonti E; Teles RC; Rigattieri S; Gregori D; Tamburino C; Burzotta F
EuroIntervention; 2023 Feb; 18(13):e1108-e1119. PubMed ID: 36043326
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA; Maehara A; Généreux P; Shlofmitz RA; Fabbiocchi F; Nazif TM; Guagliumi G; Meraj PM; Alfonso F; Samady H; Akasaka T; Carlson EB; Leesar MA; Matsumura M; Ozan MO; Mintz GS; Ben-Yehuda O; Stone GW;
Lancet; 2016 Nov; 388(10060):2618-2628. PubMed ID: 27806900
[TBL] [Abstract][Full Text] [Related]
9. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
Valgimigli M; Cao D; Angiolillo DJ; Bangalore S; Bhatt DL; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; Choi JW; Campo G; De la Torre Hernandez JM; Kunadian V; Sardella G; Thiele H; Varenne O; Vranckx P; Windecker S; Zhou Y; Krucoff MW; Ruster K; Zheng Y; Mehran R;
J Am Coll Cardiol; 2021 Nov; 78(21):2060-2072. PubMed ID: 34794687
[TBL] [Abstract][Full Text] [Related]
10. Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound.
Kang DY; Ahn JM; Yun SC; Hur SH; Cho YK; Lee CH; Hong SJ; Lim S; Kim SW; Won H; Oh JH; Choe JC; Hong YJ; Yoon YH; Kim H; Choi Y; Lee J; Yoon YW; Kim SJ; Bae JH; Park SJ; Park DW;
J Am Coll Cardiol; 2024 Jan; 83(3):401-413. PubMed ID: 37879490
[TBL] [Abstract][Full Text] [Related]
11. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
12. Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome-propensity score matching analysis.
Zhao Y; Yang Y; Guo L; Shen D; Dong Z; Lin Y; Liu H; Wei Y; Zhang B
BMC Cardiovasc Disord; 2024 Jan; 24(1):58. PubMed ID: 38238660
[TBL] [Abstract][Full Text] [Related]
13. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
[TBL] [Abstract][Full Text] [Related]
14. 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation.
Mehran R; Cao D; Angiolillo DJ; Bangalore S; Bhatt DL; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; De la Torre Hernandez JM; Kunadian V; Sardella G; Thiele H; Varenne O; Vranckx P; Windecker S; Zhou Y; Krucoff MW; Ruster K; Wang J; Valgimigli M;
JACC Cardiovasc Interv; 2021 Sep; 14(17):1870-1883. PubMed ID: 34503737
[TBL] [Abstract][Full Text] [Related]
15. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Valgimigli M; Smits PC; Frigoli E; Bongiovanni D; Tijssen J; Hovasse T; Mafragi A; Ruifrok WT; Karageorgiev D; Aminian A; Garducci S; Merkely B; Routledge H; Ando K; Diaz Fernandez JF; Cuisset T; Nesa Malik FT; Halabi M; Belle L; Din J; Beygui F; Abhyankar A; Reczuch K; Pedrazzini G; Heg D; Vranckx P;
Eur Heart J; 2022 Sep; 43(33):3100-3114. PubMed ID: 35580836
[TBL] [Abstract][Full Text] [Related]
16. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.
Valgimigli M; Spirito A; Sartori S; Angiolillo DJ; Vranckx P; de la Torre Hernandez JM; Krucoff MW; Bangalore S; Bhatt DL; Campo G; Cao D; Chehab BM; Choi JW; Feng Y; Ge J; Hermiller J; Kunadian V; Lupo S; Makkar RR; Maksoud A; Neumann FJ; Picon H; Saito S; Sardella G; Thiele H; Toelg R; Varenne O; Vogel B; Zhou Y; Windecker S; Mehran R
JACC Cardiovasc Interv; 2023 Oct; 16(20):2498-2510. PubMed ID: 37804290
[TBL] [Abstract][Full Text] [Related]
17. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Zocca P; Kok MM; van der Heijden LC; van Houwelingen KG; Hartmann M; de Man FHAF; Stoel MG; Louwerenburg JHW; Knottnerus IL; Linssen GCM; Doggen CJM; von Birgelen C
Int J Cardiol; 2018 Oct; 268():11-17. PubMed ID: 29801763
[TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial.
Kang DY; Ahn JM; Yun SC; Hur SH; Cho YK; Lee CH; Hong SJ; Lim S; Kim SW; Won H; Oh JH; Choe JC; Hong YJ; Yoon YH; Kim H; Choi Y; Lee J; Yoon YW; Kim SJ; Bae JH; Park DW; Park SJ;
Circulation; 2023 Oct; 148(16):1195-1206. PubMed ID: 37634092
[TBL] [Abstract][Full Text] [Related]
19. Early Strut Coverage in Patients Receiving Drug-Eluting Stents and its Implications for Dual Antiplatelet Therapy: A Randomized Trial.
Lee SY; Kim JS; Yoon HJ; Hur SH; Lee SG; Kim JW; Hong YJ; Kim KS; Choi SY; Shin DH; Nam CM; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1810-1819. PubMed ID: 29454763
[TBL] [Abstract][Full Text] [Related]
20. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ
BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
